Cargando…
A Propensity Score-Matched Study on the Changes of TB Status and TB-IGRA Values in Patients with Psoriasis with Latent TB Receiving Secukinumab
INTRODUCTION: The utilization of biologics in patients with psoriasis with latent tuberculosis infection (LTBI) has garnered significant attention. Although the tuberculosis (TB) safety profile of second-generation biologics, including secukinumab, has been partially confirmed in both clinical trial...
Autores principales: | Xiao, Yue, Mi, Wenyao, Wang, Jinqiu, Wen, Dingke, Wang, Yiyi, Gu, Yuanxia, Hao, Dan, Yan, Wei, Chen, Xuerong, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539261/ https://www.ncbi.nlm.nih.gov/pubmed/37615837 http://dx.doi.org/10.1007/s13555-023-00998-w |
Ejemplares similares
-
IGRA test for TB in COVID-19: role of corticosteroids
por: Granozzi, B., et al.
Publicado: (2022) -
First evaluation of the performance of portable IGRA, QIAreach® QuantiFERON®-TB in intermediate TB incidence setting
por: Aziz, Zirwatul Adilah, et al.
Publicado: (2023) -
Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting
por: Sharma, Surendra K., et al.
Publicado: (2017) -
VIDAS(®) TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
por: Petruccioli, E., et al.
Publicado: (2022) -
The association between diabetes status and latent-TB IGRA levels from a cross-sectional study in eastern China
por: Chen, Cheng, et al.
Publicado: (2023)